Quantcast

Latest multiple sclerosis Stories

2014-08-21 12:26:32

NORWALK, Conn., Aug. 21, 2014 /PRNewswire/ -- UBM Medica US announces that Neurology Times, a leading online community and information resource for neurologists and other healthcare providers features special coverage on multiple sclerosis, devoted to fostering better treatment of patients who have the disorder. MS affects 2.5 million persons worldwide, including more than 400,000 Americans, and is the most common disabling neurologic disease of young adults. Although there is no cure or...

2014-08-19 23:06:34

According to new report from BCC Research,the global market for multiple sclerosis (MS) disease-modifying products reached nearly $10.9 billion in 2013. This is estimated to grow to nearly $14.2 billion by 2018 with a compound annual growth rate (CAGR) of 5.4% from 2013 through 2018. (PRWEB) August 19, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, MULTIPLE SCLEROSIS (MS) DRUGS AND BIOLOGICS: TECHNOLOGIES AND GLOBAL MARKETS, the global market for multiple...

2014-08-15 23:03:49

Author tells story of adoption gone wrong, a dysfunctional childhood, and living with multiple sclerosis. Orlando, Florida (PRWEB) August 15, 2014 First time Author, Kevin A. Porreco, releases his personal story of being given-up for adoption, raised in a dysfunctional and violent home, and then being diagnosed with a chronic illness. Kevin gives his readers a first hand account of his dysfunctional childhood, as an only child. As he approaches and enters adulthood without the help or...

2014-08-14 08:28:23

-- Expanded Data from Phase II MS Trial to be Released Next Month; Plans on Course to Advance C. difficile and C-IBS Programs into the Clinic During 2014 -- ROCKVILLE, Md., Aug. 14, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, today reported financial results for the three and six months ended June 30, 2014, and provided an operational...

2014-08-11 08:28:00

COPENHAGEN, Denmark, Aug. 11, 2014 /PRNewswire/ -- Forward Pharma A/S, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis, today announced that Joel Sendek, 47, has been appointed Chief Financial Officer, effective August 5, 2014. Mr. Sendek will serve as a key member of the executive team providing strategic leadership for the Company's financial functions and be responsible for the Company's short and...

2014-08-07 12:28:48

Biogen Idec's Tecfidera is Forecast to Overtake Teva's Copaxone Franchise as the U.S. Market Leader by 2015, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 7, 2014 /PRNewswire/ -- Decision Resources Group finds that the forecast launch of Biogen Idec's Plegridy, Roche/Genentech's ocrelizumab, Biogen Idec/AbbVie's daclizumab, Teva/Active Biotech's Nerventra and Receptos' RPC-1063, coupled with the expected U.S. approval of Genzyme/Sanofi/Bayer HealthCare's...

2014-07-31 08:34:53

-- Oral Presentation to Include Greater Detail on Clinical Outcomes, Including Significant and Unique Improvements in Cognition -- ROCKVILLE, Md., July 31, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that Rhonda Voskuhl, M.D., the lead investigator of the Phase II clinical trial evaluating...

2014-07-29 23:00:39

DailyGossip.org reveals in its latest review that a new program, the Natural Multiple Sclerosis Treatment, has been developed for sufferers to access a natural, safe way of stopping multiple sclerosis. Denver, Colorado (PRWEB) July 29, 2014 The Natural Multiple Sclerosis Treatment review recently published by Daily Gossip reveals the inside story to Gary M. Levin’s cure program. Levin claims to have discovered a remarkable cure method for this serious disorder. Levin says that multiple...

2014-07-26 23:01:46

MarketOptimizer.org adds “Multiple Sclerosis Global Clinical Trials Review, H2, 2014” to its store. Inquire before buying at http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9010. Dallas, TX (PRWEB) July 26, 2014 Multiple sclerosis (MS), also known as disseminated sclerosis or encephalomyelitis disseminata, is an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of...

2014-07-24 08:34:45

Net Sales $279 Million; Increase of 42% over Prior Year Non-GAAP Results ANAHEIM, Calif., July 24, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the second quarter ended June 30, 2014. Three Months Ended Three Months Ended 06/30/14 06/30/13 Percentage Change --------------------- --------------------- ----------------- GAAP Net Sales...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related